Aspirin in patients undergoing noncardiac surgery

New England Journal of Medicine

Volumn 370, Issue 16, 2014, Pages 1494-1503

  Devereaux, P J ^a,b   Mrkobrada, M ^a,c   Sessler, D I ^h   Leslie, K ⁱ   Alonso Coello, P ^j   Kurz, A ^h   Villar, J C ^k   Sigamani, A ^l   Biccard, B M ^m   Meyhoff, C S ⁿ   Parlow, J L ^d   Guyatt, G ^b   Robinson, A ^a   Garg, A X ^e   Rodseth, R N ^m   Botto, F ^a,o   Lurati Buse, G ^a,p   Xavier, D ^l   Chan, M T V ^q   Tiboni, M ^b   Cook, D ^b   Kumar, P A ^r   Forget, P ^s   Malaga, G ^t   Fleischmann, E ^u   Amir, M ^v   Eikelboom, J ^a,b   Mizera, R ^b   Torres, D ^w   Wang, C Y ^x   VanHelder, T ^b   Paniagua, P ^j   Berwanger, O ^y   Srinathan, S ^f   Graham, M ^g   Pasin, L ^z   Le Manach, Y ^a,b   Gao, P ^a   Pogue, J ^a,b   Whitlock, R ^a,b   Lamy, A ^a,b   Kearon, C ^b   Baigent, C ^aa   Chow, C ^ab   Pettit, S ^a   Chrolavicius, S ^a   Yusuf, S ^a,b   more..

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ ROYAL MELBOURNE HOSPITAL   (Australia)

^j BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^k UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^l ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^m UNIVERSITY OF KWAZULU NATAL   (South Africa)

ⁿ UNIVERSITY OF COPENHAGEN   (Denmark)

^o INSTITUTO CARDIOVASCULAR DE BUENOS AIRES   (Argentina)

^p UNIVERSITY HOSPITAL BASEL   (Switzerland)

^q CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^r UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^s CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^t UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^u MEDICAL UNIVERSITY OF VIENNA   (Austria)

^v SHIFA INTERNATIONAL HOSPITAL   (Pakistan)

^w CLÍNICA SANTA MARÍA   (Chile)

^x UNIVERSITY OF MALAYA   (Malaysia)

^y HCor Research Institute Hospital Do Coração   (Brazil)

^z SAN RAFFAELE HOSPITAL   (Italy)

^aa UNIVERSITY OF OXFORD   (United Kingdom)

^ab UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLONIDINE; PLACEBO;

AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DEATH; DRUG EFFECT; DRUG WITHDRAWAL; FACTORIAL DESIGN; FEMALE; FOLLOW UP; HAZARD RATIO; HEART INFARCTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONCARDIAC SURGERY; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT DURATION;

AGED; ASPIRIN; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE; SURGICAL PROCEDURES, OPERATIVE; TREATMENT FAILURE;

EID: 84898651927     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1401105     Document Type: Article

References (31)

1. Botto F, Alonso-Coello P, Chan MTV, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 2014;120:564-78.
2. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012;307:2295-304. [Erratum, JAMA 2012;307:2590.]
3. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 2011;154:523-8.
4. Naesh O, Friis JT, Hindberg I, Winther K. Platelet function in surgical stress. Thromb Haemost 1985;54:849-52. (Pubitemid 16179931)
5. Devereaux PJ, Chan M, Eikelboom J. Major vascular complications in patients undergoing non-cardiac surgery: magnitude of the problem, risk prediction, surveillance, and prevention. In: Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ, eds. Evidence based cardiology. 3rd ed. Chichester, England: Wiley-Blackwell, 2010:47-62.
6. Gualandro DM, Campos CA, Calderaro D, et al. Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. Atherosclerosis 2012;222:191-5.
7. Reilly IA, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 1987;69:180-6. (Pubitemid 17007095)
8. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88:787-800. (Pubitemid 32823829)
9. Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-60.
10. The CURRENT-OASIS 7 Investigators. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 2010;363:930-42. [Erratum, N Engl J Med 2010;363:1585.]
11. Taylor DW, Barnett HJ, Haynes RB, et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. Lancet 1999;353:2179-84. (Pubitemid 29295249)
12. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86. [Erratum, BMJ 2002;324:141.]
13. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302.
14. Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.
15. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94. [Erratum, Lancet 2008; 371:1914l.] (Pubitemid 351173321)
16. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47.
17. Hiralal R, Guyatt G, Bhandari M, et al. A survey evaluating surgeons' perioperative usage of acetyl-salicylic acid (ASA) and their willingness to enroll their patients in a perioperative ASA randomized controlled trial. Clin Invest Med 2010;33:E375-E383.
18. Neilipovitz DT, Bryson GL, Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001;93:573-80. (Pubitemid 32783276)
19. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005;257:399-414. (Pubitemid 40604544)
20. Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014; 370:1504-13.
21. Devereaux PJ, Sessler DI, Mrkobrada M, et al. Rationale and design of the Peri-Operative ISchemic Evaluation-2 (POISE-2) Trial: an international 2 x 2 factorial randomized controlled trial of acetylsalicylic acid versus placebo and clonidine versus placebo in patients undergoing noncardiac surgery. Am Heart J 2014 (http://www.ahjonline.com/article/S0002-8703(14)00077-5/fulltext).
22. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. (Pubitemid 29416229)
23. Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively? Clinical impact of aspirin withdrawal syndrome. Ann Surg 2012;255:811-9.
24. Kamel H, Johnston SC, Kirkham JC, et al. Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation 2012; 126:207-12.
25. Bradlow BA, Chetty N. Dosage frequency for suppression of platelet function by low dose aspirin therapy. Thromb Res 1982;27:99-110. (Pubitemid 12061761)
26. Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation 1985;72:1177-84. (Pubitemid 16126796)
27. Cerskus AL, Ali M, Davies BJ, McDonald JW. Possible significance of small numbers of functional platelets in a population of aspirin-treated platelets in vitro and in vivo. Thromb Res 1980;18:389-97. (Pubitemid 10090409)
28. O'Brien JR. Effects of salicylates on human platelets. Lancet 1968;1:779-83.
29. Sun X, Briel M, Walter SD, Guyatt GH. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ 2010;340:c117.
30. Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med 2013;158:800-6.
31. Albaladejo P, Marret E, Samama CM, et al. Non-cardiac surgery in patients with coronary stents: the RECO study. Heart 2011;97:1566-72.